Searched for
OHM LABORATORIES
Past issues, heavy attrition at the root of Ranbaxy’s problems: Ranjit Kapadia, Centrum Broking"We have a 'sell' rating with a target price of Rs 360. Now we have to watch the situation today as it unfolds and accordingly, we will tak...24 Jan, 2014, 01.12 PM IST- Ranbaxy gets Health Canada nod for generic anti-dementia drugDrug maker Ranbaxy Laboratories today announced receipt of approval from Health Canada to sell generic version of Pfizer's Aricept.08 Jan, 2014, 06.58 PM IST
- Ranbaxy's US unit gets USFDA's establishment inspection reportThe US health regulator has given Ranbaxy Laboratories' American arm Ohm Laboratories Inc a report indicating closure of inspection of its ...12 Oct, 2013, 07.50 AM IST
- Ranbaxy may shift key drug filings from Mohali to USConsidering its US facility is already running chock-a-bloc, analysts feel, the company may cherry-pick and transfer its first to file ANDA...02 Oct, 2013, 07.24 AM IST
- Ranbaxy shares fall over 5% as trouble brews in US marketThe stock plunged over 5% on reports that the US-based Ohm Laboratories-the company's facility in US, is under the surveillance of FDA.20 Sep, 2013, 10.29 AM IST
- Ranbaxy restarts generic Lipitor production for US marketPharma major Ranbaxy Laboratories restarts production of generic cholesterol lowering drug Atorvastatin as it looks to resume supplies to U...25 Feb, 2013, 02.15 PM IST
- Ranbaxy begins Atorvastation exports to USRanbaxy Laboratories has commenced exports of Atorvastation Calcium tablets to the US market from its Mohali SEZ manufacturing facility.03 Apr, 2012, 05.55 AM IST
- Ranbaxy starts generic Lipitor shipments from IndiaRanbaxy Laboratories Ltd has started exports of a copycat version of blockbuster cholesterol drug Lipitor from a new facility in India.02 Apr, 2012, 02.59 PM IST
- Ranbaxy gains over 11 pc in morning trade on boursesShares of Ranbaxy Laboratories jumped by over 11 per cent in morning trade on the bourses today after the drug major launched Lipitor in th...01 Dec, 2011, 11.15 AM IST
- Angel recommends 'Sell' on Ranbaxy LaboratoriesAngel Broking has recommended a sell rating for Ranbaxy Laboratories after a warning was issued against the company from US FDA for its Ohm...29 Dec, 2009, 11.21 AM IST
- Ranbaxy Laboratories is over-priced: EmkayEmkay Global Financial Services is of the view that the warning to Ranbaxy Laboratories’ Ohm plant will sentimentally dampen its stock pric...29 Dec, 2009, 11.09 AM IST
- US FDA issues warning letter to Ranbaxy's American subsidiaryThe US Food and Drug Administration issued a warning letter to Ranbaxy Labs' American subsidiary for violating current good manufacturing p...24 Dec, 2009, 05.34 PM IST
- Ranbaxy, Aurobindo get US FDA nod for epilepsy drugPharma firm Ranbaxy on Monday said it has received US regulatory approval for Topiramate tablets, used in the treatment of epilepsy.30 Mar, 2009, 02.45 PM IST
- Ranbaxy gets USFDA nod for RamiprilRanbaxy Laboratories has received the final approval from the US Food and Drug Administration’s to sell Ramipril capsules (in 5mg & 10mg), ...09 Mar, 2009, 02.08 PM IST
- Ranbaxy gets nod to market Cetirizine in USRanbaxy Laboratories has received final approval from the US Food and Drug Administration to manufacture and market Cetirizine Hydrochlorid...25 Apr, 2008, 07.20 PM IST
- Ranbaxy, Cadila gets USFDA nod for CarvedilolRanbaxy Laboratories and Cadila Healthcare have received approval from the USFDA for Carvedilol tablets in the strengths - 3.125 mg, 6.25 m...06 Sep, 2007, 05.13 PM IST
- Ranbaxy gets USFDA nod for diabetic drugDrug maker Ranbaxy's wholly-owned US subsidiary receives USFDA approval to market Metformin Hydrochloride tablets.13 Aug, 2007, 11.35 AM IST
Load More
